Combination of lapatinib with isothiocyanates overcomes drug resistance and inhibits migration of HER2 positive breast cancer cells
Crossref DOI link: https://doi.org/10.1007/s12282-016-0700-9
Published Online: 2016-05-06
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
KaczyĆska, Angelika
Herman-Antosiewicz, Anna
Funding for this research was provided by:
National Science Centre (Poland) (N N301 601740)
License valid from 2016-05-06